Cytek Biosciences, Inc.
CTKB
$5.36
-$0.03-0.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.82M | -6.40M | -11.25M | -6.02M | -10.16M |
| Total Depreciation and Amortization | 11.67M | 11.42M | 10.91M | 10.49M | 10.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.05M | 10.18M | 12.74M | 13.20M | 23.51M |
| Change in Net Operating Assets | -6.82M | 3.00K | 8.90M | 7.71M | 9.37M |
| Cash from Operations | -1.92M | 15.20M | 21.30M | 25.38M | 32.89M |
| Capital Expenditure | -3.98M | -4.33M | -3.81M | -3.53M | -4.13M |
| Sale of Property, Plant, and Equipment | 248.00K | 268.00K | 321.00K | 288.00K | 97.00K |
| Cash Acquisitions | -471.00K | -471.00K | -471.00K | -471.00K | -236.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -47.27M | -81.67M | -63.81M | -79.27M | 13.80M |
| Cash from Investing | -51.47M | -86.20M | -67.77M | -82.97M | 9.53M |
| Total Debt Issued | 6.95M | 4.87M | 3.48M | 4.18M | 1.40M |
| Total Debt Repaid | -1.94M | -1.94M | -1.94M | -557.00K | -558.00K |
| Issuance of Common Stock | 1.78M | 1.79M | 2.25M | 2.72M | 3.11M |
| Repurchase of Common Stock | -22.63M | -34.59M | -32.77M | -22.17M | -49.89M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -15.85M | -29.87M | -28.98M | -15.82M | -45.94M |
| Foreign Exchange rate Adjustments | 215.00K | -1.57M | 1.61M | 4.53M | 2.19M |
| Miscellaneous Cash Flow Adjustments | 0.00 | -1.00K | -- | -- | -- |
| Net Change in Cash | -69.02M | -102.45M | -73.84M | -68.89M | -1.33M |